[10-7-2024] The Food and Drug Administration is advising consumers not to purchase or use Trinity Gold, a product promoted and sold for joint and muscle pain […]

Please visit Regulatory Status of Color Additives for the status of color additives for use in foods, drugs, cosmetics, and some medical devices in the U.S. The list […]

For Immediate Release: October 04, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, […]

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

As part of the U.S. Food and Drug Administration (FDA), the Center for Drug Evaluation and research (CDER) regulates over-the-counter and prescription drugs, including biological therapeutics […]

Quick Links Notices The eCTD is the standard format for submitting applications, amendments, supplements, and reports to FDA’s Center for Drug Evaluation and Research (CDER) and […]

The FDA is continuing its efforts to build and leverage strong working relationships with state regulators in our collective efforts to oversee drug compounding. With the […]

English ¿Qué es la semaglutida? La semaglutida pertenece a una clase de medicamentos conocidos como agonistas de los receptores del péptido-1 similar al glucagón (GLP-1). Imita […]

On This Page Date: November 12, 2024 Time: 11:00 AM – 12:00 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT (Hosted […]